Abstract
Hemorrhage remains a critical factor contributing to avoidable fatalities in combat scenarios and civilian emergencies. Significant advancements have been made in managing extremity hemorrhage through tourniquet application, although not all injuries can be effectively treated with this method. In the United States, the Committee on Tactical Combat Casualty Care (CoTCCC) has emphasized the importance of employing hemostatic dressings during initial trauma care as an alternative when tourniquet application is not feasible. Similar recommendations have been adopted globally, highlighting the pivotal role of topical hemostats in managing such critical situations. Among the recommended topical hemostats, hemostatic gauze, composed of biomaterials including chitosan and kaolin, has demonstrated superior efficacy in rapidly achieving hemostasis. The objective of this study was to evaluate the hemostatic efficacy of axiostat gauze (AG) in an extremity arterial hemorrhage model in swine and compare it with QuikClot Combat Gauze (QCG). The femoral artery was selected to create a model of severe arterial hemorrhage. This model is widely accepted as a standardized combat injury model by military laboratories, including those of the US Department of Defense. The findings indicate that AG has a superior safety profile, evidenced by the absence of particle release, and offers advantages in terms of faster hemostasis, reduced overall blood loss, and greater fluid absorbency compared to QCG. Although AG achieved quicker hemostasis, both AG and QCG ultimately provided effective eventual hemostasis in all animals, demonstrating comparable overall efficacy. In addition to its hemostatic performance, AG also possesses antimicrobial properties and is biocompatible. These attributes make AG a highly effective option for managing severe traumatic bleeding. Thus, AG can be recommended for use in both military and civilian pre-hospital settings as a strategic solution for critical bleeding situations.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Health Technology and Innovation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.